Periprocedural Myocardial Necrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-10-26
Clinical Trial Update: Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs) [Phase 3]
A Phase 3 trial evaluating rosuvastatin to prevent periprocedural myocardial necrosis during elective percutaneous coronary interventions ha…